PT-141 — Vendor Comparison
Bremelanotide, a melanocortin receptor agonist studied for its effects on sexual dysfunction. FDA-approved as Vyleesi for HSDD in premenopausal women.
Rankings based on our Vendor Transparency Score — COA publishing, lab accreditation, batch traceability, and published policies.See our methodology →
We earn commissions from some vendors below. This doesn't affect our rankings — they're determined by Vendor Transparency Scores alone.Full disclosure →
How We Score Transparency
Public COA AccessCore evidenceCertificates of Analysis visible on site with batch-specific results
Batch TraceabilityCore evidenceCOA batch numbers match product labels and packaging
Named Testing LabCore evidenceTesting lab is named and independently verifiable
Policy PagesSupporting trustDedicated refund and/or shipping policy pages
Identifiable OwnershipSupporting trustNamed founders, registered business, or physical address
Methodology v3.0 · Last updated Mar 14, 2026Full methodology →